Literature DB >> 22208282

Peculiarities of copper binding to alpha-synuclein.

Atta Ahmad1, Colin S Burns, Anthony L Fink, Vladimir N Uversky.   

Abstract

Heavy metals have been implicated as the causative agents for the pathogenesis of the most prevalent neurodegenerative disease. Various mechanisms have been proposed to explain the toxic effects of metals ranging from metal-induced oxidation of protein to metal-induced changes in the protein conformation. Aggregation of a-synuclein is implicated in Parkinson's disease (PD), and various metals, including copper, constitute a prominent group of alpha-synuclein aggregation enhancers. In this study, we have systematically characterized the a-synuclein-Cu21 binding sites and analyzed the possible role of metal binding in a-synuclein fibrillation using a set of biophysical techniques, such as electron paramagnetic resonance (EPR), electron spin-echo envelope modulation (ESEEM), circular dichroism (CD), and size exclusion chromatography (SEC). Our analyses indicated that a-synuclein possesses at least two binding sites for Cu21. We have been able to locate one of the binding sites in the N-terminal region. Furthermore, based on the EPR studies of model peptides and Beta-synuclein, we concluded that the suspected His residue did not appear to participate in strong Cu21 binding.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22208282     DOI: 10.1080/073911012010525023

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  12 in total

1.  Native Top-Down Mass Spectrometry and Ion Mobility MS for Characterizing the Cobalt and Manganese Metal Binding of α-Synuclein Protein.

Authors:  Piriya Wongkongkathep; Jong Yoon Han; Tae Su Choi; Sheng Yin; Hugh I Kim; Joseph A Loo
Journal:  J Am Soc Mass Spectrom       Date:  2018-06-27       Impact factor: 3.109

2.  The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.

Authors:  Julia Bornhorst; Sudipta Chakraborty; Sören Meyer; Hanna Lohren; Sigrid Grosse Brinkhaus; Adam L Knight; Kim A Caldwell; Guy A Caldwell; Uwe Karst; Tanja Schwerdtle; Aaron Bowman; Michael Aschner
Journal:  Metallomics       Date:  2014-01-22       Impact factor: 4.526

3.  Comparison of the structural characteristics of Cu(2+)-bound and unbound α-syn12 peptide obtained in simulations using different force fields.

Authors:  Zanxia Cao; Lei Liu; Liling Zhao; Haiyan Li; Jihua Wang
Journal:  J Mol Model       Date:  2012-11-18       Impact factor: 1.810

Review 4.  Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review.

Authors:  Aswir Abd Rashed; Ahmad Zuhairi Abd Rahman; Devi Nair Gunasegavan Rathi
Journal:  Molecules       Date:  2021-02-19       Impact factor: 4.411

5.  Protein intrinsic disorder in the acetylome of intracellular and extracellular Toxoplasma gondii.

Authors:  Bin Xue; Victoria Jeffers; William J Sullivan; Vladimir N Uversky
Journal:  Mol Biosyst       Date:  2013-04-05

6.  Expression and Transport of α-Synuclein at the Blood-Cerebrospinal Fluid Barrier and Effects of Manganese Exposure.

Authors:  Christopher A Bates; Sherleen Fu; Daniel Ysselstein; Jean-Christophe Rochet; Wei Zheng
Journal:  ADMET DMPK       Date:  2015-03-31

7.  Acetylation Rather than H50Q Mutation Impacts the Kinetics of Cu(II) Binding to α-Synuclein.

Authors:  Xiangyu Teng; Alena Sheveleva; Floriana Tuna; Keith R Willison; Liming Ying
Journal:  Chemphyschem       Date:  2021-10-14       Impact factor: 3.520

Review 8.  Oxidative Stress and Its Clinical Applications in Dementia.

Authors:  Peizhong Mao
Journal:  J Neurodegener Dis       Date:  2012-08-30

Review 9.  Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism.

Authors:  Vladimir N Uversky
Journal:  F1000Res       Date:  2017-04-20

10.  Essential Oils May Lead α-Synuclein towards Toxic Fibrils Formation.

Authors:  Dina Morshedi; Mahour Nasouti
Journal:  Parkinsons Dis       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.